Conning Inc’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-11,482
Closed -$1.14M 518
2019
Q3
$1.14M Buy
11,482
+20
+0.2% +$1.9K 0.04% 202
2019
Q2
$1.06M Sell
11,462
-1,972
-15% -$187K 0.04% 213
2019
Q1
$1.27M Sell
13,434
-340
-2% -$29.7K 0.04% 225
2018
Q4
$883K Sell
13,774
-3,610
-21% -$266K 0.03% 243
2018
Q3
$1.56M Sell
17,384
-1,950
-10% -$172K 0.05% 216
2018
Q2
$1.54M Sell
19,334
-2,780
-13% -$231K 0.05% 228
2018
Q1
$1.97M Buy
22,114
+1,790
+9% +$172K 0.06% 186
2017
Q4
$2.12M Sell
20,324
-430
-2% -$48.5K 0.07% 178
2017
Q3
$3.03M Sell
20,754
-90
-0.4% -$12.3K 0.1% 143
2017
Q2
$2.71M Sell
20,844
-96
-0.5% -$11.8K 0.1% 149
2017
Q1
$2.61M Sell
20,940
-1,535
-7% -$184K 0.1% 149
2016
Q4
$2.6M Buy
22,475
+2,955
+15% +$329K 0.1% 148
2016
Q3
$2.04M Buy
19,520
+60
+0.3% +$6.49K 0.08% 180
2016
Q2
$1.92M Buy
19,460
+30
+0.2% +$3.1K 0.08% 189
2016
Q1
$1.95M Buy
19,430
+320
+2% +$33K 0.08% 175
2015
Q4
$2.29M Sell
19,110
-1,090
-5% -$126K 0.1% 161
2015
Q3
$2.19M Sell
20,200
-2,110
-9% -$262K 0.1% 157
2015
Q2
$2.58M Sell
22,310
-350
-2% -$40K 0.11% 150
2015
Q1
$2.61M Sell
22,660
-1,390
-6% -$166K 0.11% 136
2014
Q4
$2.69M Sell
24,050
-800
-3% -$84.4K 0.13% 124
2014
Q3
$2.35M Sell
24,850
-1,310
-5% -$118K 0.12% 127
2014
Q2
$2.25M Sell
26,160
-440
-2% -$33.5K 0.12% 133
2014
Q1
$1.86M Buy
26,600
+1,060
+4% +$83.9K 0.11% 149
2013
Q4
$2.16M Sell
25,540
-262
-1% -$20.7K 0.13% 120
2013
Q3
$1.99M Buy
25,802
+5,022
+24% +$352K 0.15% 118
2013
Q2
$1.22M Buy
+20,780
New +$1.25M 0.1% 156

Other funds holding CELG

Conning Inc's CELG Position: Q4 2019 in Review

Conning Inc sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,482 shares — an estimated $1.14M sold.

Conning Inc first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.03M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Conning Inc reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Conning Inc sold 11,482 Celgene Corp shares in Q4 2019, an estimated $1.14M.
  • Conning Inc first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Conning Inc's Celgene Corp position peaked at $3.03M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Conning Inc's 13F filing for Q4 2019, filed 29 Jan 2020.